Use of opioid use disorder medications more than tripled among beneficiaries from 2018 to 2021
Research published recently in Health Affairs finds that use of medications for opioid use disorder (MOUD) dramatically increased among Medicaid enrollees in Louisiana after lawmakers enacted a host of policy changes designed to better address the opioid crisis and help people access evidence-based treatment.
The study, conducted by researchers from Johns Hopkins Bloomberg School of Public Health, examined 2018-21 claims data for Medicaid enrollees diagnosed with OUD who were receiving treatment in both residential and outpatient facilities. Medicaid is the public health care program financed jointly by the state and federal governments.
Tags: Addiction Services Harm Reduction Opioid Epidemic Programs Research Study Treatment
